在一名 23 公斤重的先天性心脏病儿科患者中进行 Aveir 可回收、38 毫米长的无导线起搏器植入。
Aveir retrievable, 38-mm length, leadless pacemaker implantation in a 23-kg pediatric patient with congenital heart disease.
机构信息
Department of Pediatric Cardiology, UC Davis Medical Center, Sacramento, USA.
Santa Clara University, Santa Clara, USA.
出版信息
Pacing Clin Electrophysiol. 2024 Mar;47(3):398-400. doi: 10.1111/pace.14934. Epub 2024 Feb 11.
INTRODUCTION
Complications are more prevalent in pediatric patients receiving pacemaker implants.
METHODS
We performed a retrospective review of a retrievable, 38 mm leadless pacemaker implantation in a 23-kg pediatric patient.
CASE/DISCUSSION: An active 9-year-old, 23 kg male patient with tetralogy of Fallot with intermittent pacing need presented with a fractured lead and pacing need. He underwent implant of a retrievable leadless pacemaker (Abbott Aveir) via internal jugular vein access, without complication, and with echocardiographic guidance. His threshold was stable at 1.25 V @0.4 ms, with stable impedance and sensing at 5-month follow-up.
CONCLUSION
Aveir retrievable leadless pacemakers can be implanted safely in a child with tetralogy of Fallot, as small as 23 kilograms.
简介
接受起搏器植入的儿科患者更易出现并发症。
方法
我们对一名 23 公斤的儿科患者进行了可回收 38 毫米无导线起搏器植入的回顾性研究。
病例/讨论：一名 9 岁、23 公斤的活跃男性先心患者，法洛四联症，间歇性起搏需求，出现导线断裂和起搏需求。他通过颈内静脉入路植入了可回收无导线起搏器（雅培 Aveir），无并发症，并在超声心动图引导下进行。他的阈值在 1.25 V@0.4 ms 时稳定，在 5 个月的随访时阻抗和感知稳定。
结论
Aveir 可回收无导线起搏器可安全植入体重低至 23 公斤的法洛四联症患儿体内。
Zotero 插件